Filing Details
- Accession Number:
- 0001209191-22-002297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-06 21:02:00
- Reporting Period:
- 2022-01-04
- Accepted Time:
- 2022-01-06 21:02:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792746 | Andy Pasternak | C/O Horizon Therapeutics Plc, 70 Saint Stephen?S Green Dublin L2 D02 E2X4 | Evp And Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2022-01-05 | 48,839 | $0.00 | 70,669 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2022-01-05 | 21,710 | $101.84 | 48,959 | No | 4 | F | Direct | |
| Ordinary Shares | Disposition | 2022-01-06 | 500 | $97.30 | 48,459 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-01-06 | 700 | $98.33 | 47,759 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-01-06 | 6,438 | $99.85 | 41,321 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-01-06 | 349 | $100.23 | 40,972 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units (RSU) | Acquisiton | 2022-01-04 | 23,805 | $0.00 | 23,805 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2022-01-05 | 14,514 | $0.00 | 14,514 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2022-01-05 | 11,642 | $0.00 | 11,642 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2022-01-05 | 11,067 | $0.00 | 11,067 | $0.00 |
| Ordinary Shares | Restricted Stock Units (RSU) | Disposition | 2022-01-05 | 11,616 | $0.00 | 11,616 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,805 | No | 4 | A | Direct | ||
| 14,514 | No | 4 | M | Direct | ||
| 23,286 | No | 4 | M | Direct | ||
| 11,069 | No | 4 | M | Direct | ||
| 5,800 | No | 4 | M | Direct |
Footnotes
- Each RSU represents a contingent right to receive one ordinary share of the Issuer.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2021.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.83 to $97.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.95 to $98.79 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.99 to $99.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.05 to $100.62 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The RSU's vest 1/3rd annually on each anniversary of January 5, 2022.
- The RSU's vest 1/3rd annually on each anniversary of January 5, 2021.
- 50% of the shares subject to the RSU's vested on 1/5/2022, and the remaining shares vest on 1/5/2023.
- Two-thirds of the ordinary shares subject to the RSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
Billionaire Hedge Funds
